美国 · SEC FORM 4
RAPID MICRO BIOSYSTEMS, INC.
RPID · Nasdaq · CIK 0001380106 · Healthcare · Medical Devices
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
13 同一窗口内观察到的 Form 4 交易行
0 sales · 13 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2024-12-05 · PEI MELINDA LITHERLAND · $9.5K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Spignesi Robert G. Jr.PRESIDENT AND CEO
○○
PEI MELINDA LITHERLANDDirector
○○
Malloy KirkDirector
○○
LOWENSTEIN INESEDirector
○○
Kollender Richard SDirector
○○
WIRTJES SEAN MCHIEF FINANCIAL OFFICER
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-12-05 · PEI MELINDA LITHERLAND.
近期 Form 4 活动
0买入
14卖出
19其他 Form 4 交易行
28SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他13 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 853,972
- 上期报告
- 940,376
- 日均成交量
- 374,932
- 回补天数
- 2.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-12-05 | PEI MELINDA LITHERLAND | 买入 (P) | Class A Common Stock | 9,120 | USD 1.04 | USD 9,485 | SEC 申报 ↗ |
| 2024-12-03 | PEI MELINDA LITHERLAND | 买入 (P) | Class A Common Stock | 10,880 | USD 1.00 | USD 10,880 | SEC 申报 ↗ |
| 2024-11-27 | PEI MELINDA LITHERLAND | 买入 (P) | Class A Common Stock | 19,892 | USD 1.05 | USD 20,887 | SEC 申报 ↗ |
| 2024-11-26 | PEI MELINDA LITHERLAND | 买入 (P) | Class A Common Stock | 108 | USD 1.04 | USD 112 | SEC 申报 ↗ |
| 2024-08-08 | Malloy Kirk | 买入 (P) | Class A Common Stock | 50,000 | USD 0.91 | USD 45,500 | SEC 申报 ↗ |
| 2024-08-07 | WIRTJES SEAN M | 买入 (P) | Class A Common Stock | 10,000 | USD 0.78 | USD 7,800 | SEC 申报 ↗ |
| 2024-08-06 | Spignesi Robert G. Jr. | 买入 (P) | Class A Common Stock | 50,000 | USD 0.77 | USD 38,500 | SEC 申报 ↗ |
| 2024-08-06 | Kollender Richard S | 买入 (P) | Class A Common Stock | 65,000 | USD 0.77 | USD 50,050 | SEC 申报 ↗ |
| 2023-09-06 | WIRTJES SEAN M | 买入 (P) | Class A Common Stock | 10,000 | USD 0.99 | USD 9,900 | SEC 申报 ↗ |
| 2023-08-15 | Spignesi Robert G. Jr. | 买入 (P) | Class A Common Stock | 20,000 | USD 0.97 | USD 19,400 | SEC 申报 ↗ |
| 2023-08-08 | Spignesi Robert G. Jr. | 买入 (P) | Class A Common Stock | 34,000 | USD 0.92 | USD 31,280 | SEC 申报 ↗ |
| 2023-05-17 | Spignesi Robert G. Jr. | 买入 (P) | Class A Common Stock | 19,900 | USD 0.91 | USD 18,127 | SEC 申报 ↗ |
| 2022-06-03 | CHENE DAVID; KENNEDY LEWIS INVESTMENT MANAGEMENT LLC; KENNEDY LEWIS MANAGEMENT LP; KLM GP LLC; Kennedy Lewis Capital Partners Master Fund II LP; Kennedy Lewis Capital Partners Master Fund III LP; Kennedy Lewis GP II LLC; Kennedy Lewis GP III LLC; Kennedy Lewis Investment Holdings II LLC; Richman Darren | 买入 (P) | Common Stock | 50,000 | USD 4.66 | USD 233,000 | SEC 申报 ↗ |
| 2022-06-02 | CHENE DAVID; KENNEDY LEWIS INVESTMENT MANAGEMENT LLC; KENNEDY LEWIS MANAGEMENT LP; KLM GP LLC; Kennedy Lewis Capital Partners Master Fund II LP; Kennedy Lewis Capital Partners Master Fund III LP; Kennedy Lewis GP II LLC; Kennedy Lewis GP III LLC; Kennedy Lewis Investment Holdings II LLC; Richman Darren | 买入 (P) | Common Stock | 10,100 | USD 4.99 | USD 50,399 | SEC 申报 ↗ |
| 2022-06-01 | CHENE DAVID; KENNEDY LEWIS INVESTMENT MANAGEMENT LLC; KENNEDY LEWIS MANAGEMENT LP; KLM GP LLC; Kennedy Lewis Capital Partners Master Fund II LP; Kennedy Lewis Capital Partners Master Fund III LP; Kennedy Lewis GP II LLC; Kennedy Lewis GP III LLC; Kennedy Lewis Investment Holdings II LLC; Richman Darren | 买入 (P) | Common Stock | 47,117 | USD 4.76 | USD 224,277 | SEC 申报 ↗ |
Form 4 申报证据
33 transaction lines in the latest 365-day window; 149 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Kollender Richard S | 期权行权／转换 (M) | Class A Common Stock | 3,508 | USD 0.75 | USD 2,631 | SEC 申报 ↗ |
| 2026-07-22 | Spignesi Robert G. Jr. | 期权行权／转换 (M) | Class A Common Stock | 1,402 | USD 0.75 | USD 1,052 | SEC 申报 ↗ |
| 2026-05-29 | WIRTJES SEAN M | 奖励／授予 (A) | Class A Common Stock | 12,787 | USD 1.96 | USD 25,063 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | Kollender Richard S | 期权行权／转换 (M) | Class A Common Stock | 3,508 | USD 0.75 | USD 2,631 | SEC 申报 ↗ |
| 2026-07-22 | Spignesi Robert G. Jr. | 期权行权／转换 (M) | Class A Common Stock | 1,402 | USD 0.75 | USD 1,052 | SEC 申报 ↗ |
| 2026-05-29 | WIRTJES SEAN M | 奖励／授予 (A) | Class A Common Stock | 12,787 | USD 1.96 | USD 25,063 | SEC 申报 ↗ |
| 2026-05-29 | Spignesi Robert G. Jr. | 奖励／授予 (A) | Class A Common Stock | 12,787 | USD 1.96 | USD 25,063 | SEC 申报 ↗ |
| 2026-05-29 | PEI MELINDA LITHERLAND | 奖励／授予 (A) | Class A Common Stock | 12,787 | USD 1.96 | USD 25,063 | SEC 申报 ↗ |
| 2026-05-29 | Malloy Kirk | 奖励／授予 (A) | Class A Common Stock | 12,787 | USD 1.96 | USD 25,063 | SEC 申报 ↗ |
| 2026-05-29 | LOWENSTEIN INESE | 奖励／授予 (A) | Class A Common Stock | 12,787 | USD 1.96 | USD 25,063 | SEC 申报 ↗ |
| 2026-05-21 | PEI MELINDA LITHERLAND | 奖励／授予 (A) | Class A Common Stock | 19,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Malloy Kirk | 奖励／授予 (A) | Class A Common Stock | 19,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | LOWENSTEIN INESE | 奖励／授予 (A) | Class A Common Stock | 19,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Kollender Richard S | 奖励／授予 (A) | Class A Common Stock | 19,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Bika Dafni | 奖励／授予 (A) | Class A Common Stock | 19,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-11 | Wilson John J. Addington | 卖出 (S) | Class A Common Stock | 9,603 | USD 4.32 | USD 41,485 | SEC 申报 ↗ |
| 2026-03-11 | WIRTJES SEAN M | 卖出 (S) | Class A Common Stock | 7,480 | USD 4.32 | USD 32,314 | SEC 申报 ↗ |
| 2026-03-10 | Spignesi Robert G. Jr. | 卖出 (S) | Class A Common Stock | 17,922 | USD 4.11 | USD 73,659 | SEC 申报 ↗ |
| 2026-02-27 | RICCIARDI NATALE S | 期权行权／转换 (M) | Class A Common Stock | 842 | USD 0.75 | USD 632 | SEC 申报 ↗ |
| 2026-02-20 | Wilson John J. Addington | 卖出 (S) | Class A Common Stock | 5,403 | USD 3.92 | USD 21,180 | SEC 申报 ↗ |
| 2026-02-20 | WIRTJES SEAN M | 卖出 (S) | Class A Common Stock | 17,254 | USD 3.92 | USD 67,636 | SEC 申报 ↗ |
| 2026-02-19 | Spignesi Robert G. Jr. | 卖出 (S) | Class A Common Stock | 38,327 | USD 3.89 | USD 149,092 | SEC 申报 ↗ |
| 2026-02-11 | Wilson John J. Addington | 奖励／授予 (A) | Class A Common Stock | 74,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | WIRTJES SEAN M | 奖励／授予 (A) | Class A Common Stock | 97,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Spignesi Robert G. Jr. | 奖励／授予 (A) | Class A Common Stock | 264,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | Wilson John J. Addington | 卖出 (S) | Class A Common Stock | 4,610 | USD 3.78 | USD 17,426 | SEC 申报 ↗ |
| 2026-02-09 | WIRTJES SEAN M | 卖出 (S) | Class A Common Stock | 6,027 | USD 3.78 | USD 22,782 | SEC 申报 ↗ |
| 2026-02-09 | Spignesi Robert G. Jr. | 卖出 (S) | Class A Common Stock | 12,840 | USD 3.78 | USD 48,535 | SEC 申报 ↗ |
| 2026-02-04 | ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Fund, L.P.; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet | 卖出 (S) | Class A Common Stock | 49,000 | USD 3.88 | USD 190,120 | SEC 申报 ↗ |
| 2026-02-03 | ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet | 卖出 (S) | Class A Common Stock | 27,500 | USD 4.24 | USD 116,600 | SEC 申报 ↗ |
| 2026-02-02 | ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet | 卖出 (S) | Class A Common Stock | 27,500 | USD 4.25 | USD 116,875 | SEC 申报 ↗ |
| 2026-01-30 | ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet | 卖出 (S) | Class A Common Stock | 46,000 | USD 4.54 | USD 208,840 | SEC 申报 ↗ |
| 2026-01-23 | ENRIGHT PATRICK G; Longitude Capital Partners II, LLC; Longitude Prime Partners, LLC; Longitude Venture Partners II, L.P.; Tammenoms Bakker Juliet | X (X) | Class A Common Stock | 629,032 | USD 0.05 | USD 31,452 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RPID |
| CIK | 0001380106 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 149 transaction lines from 2021-07-19 to 2026-07-24 41 P purchase lines · 19 S sale lines · 89 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.